Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2004 Feb;13(1):29–32. doi: 10.1080/09629350410001664770

Subpopulations of mononuclear leukocytes associated with inhibition of Ehrlich ascites tumor growth by treatment with Bothrops jararaca venom.

Mariana Morena de Vieira Santos 1, Reinaldo José da Silva 1, Márcia Guimarães da Silva 1, Denise Fecchio 1
PMCID: PMC1781540  PMID: 15203562

Abstract

Snake venoms have been used as antineoplastic substances in several experimental models. We demonstrated in previous studies that Bothrops jararaca venom (BjV) induces inhibition of Ehrlich ascites tumor (EAT) growth accompanied by an increase of mononuclear (MN) leukocytes in all groups inoculated with EAT and/or venom. The objective of the present study was to characterize the subpopulations of MN leukocytes involved in the inhibition of EAT growth by treatment with BjV. Swiss mice were inoculated with 1.0x10(3) EAT cells by the intraperitoneal route and treated with 0.4 mg/kg of BjV by the same route (Group TV). Treatment was started 24 h after tumor cell inoculation and consisted of five intraperitoneal injections performed at 72 h intervals. After 2, 8 and 14 days, groups of animals were sacrificed and the number of B, TCD4 and TCD8 lymphocytes, macrophages and natural killer cells present in the peritoneal cavity was determined by flow cytometry. The control group consisted of animals inoculated with EAT and treated with 0.1 ml of saline under the same conditions as the experimental group (Group T). Two additional control groups consisted of animals not inoculated with EAT and treated with saline or venom. Data were analyzed statistically by the Kruskal-Wallis non-parametric test for independent samples. On the 2nd and 8th day we observed a difference between groups T and TV (group T > group TV) for all cell types, except natural killer cells, that only differed on the 2nd day. However, on the 14th day there was no difference in MN cells among groups. These data suggest that the inhibition of EAT is related to the toxic action of BjV on tumor cells and/or to the proteolytic effect of the venom on the mediators produced by the cells for growth modulation.

Full Text

The Full Text of this article is available as a PDF (77.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gallagher G., Stimson W. H., Findlay J., al-Azzawi F. Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol Immunother. 1990;31(1):49–52. doi: 10.1007/BF01742495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Iho S., Shau H. Y., Golub S. H. Characteristics of interleukin-6-enhanced lymphokine-activated killer cell function. Cell Immunol. 1991 Jun;135(1):66–77. doi: 10.1016/0008-8749(91)90254-9. [DOI] [PubMed] [Google Scholar]
  3. Kitahara M., Kishimoto S., Hirano T., Kishimoto T., Okada M. The in vivo anti-tumor effect of human recombinant interleukin-6. Jpn J Cancer Res. 1990 Oct;81(10):1032–1038. doi: 10.1111/j.1349-7006.1990.tb03342.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Luger T. A., Krutmann J., Kirnbauer R., Urbanski A., Schwarz T., Klappacher G., Köck A., Micksche M., Malejczyk J., Schauer E. IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol. 1989 Aug 15;143(4):1206–1209. [PubMed] [Google Scholar]
  5. Okada M., Kitahara M., Kishimoto S., Matsuda T., Hirano T., Kishimoto T. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol. 1988 Sep 1;141(5):1543–1549. [PubMed] [Google Scholar]
  6. Russel S. W., Doe W. F., Cochrane C. G. Number of macrophages and distribution of mitotic activity in regressing and progressing Moloney sarcomas. J Immunol. 1976 Jan;116(1):164–166. [PubMed] [Google Scholar]
  7. Russell S. W., Doe W. F., McIntosh A. T. Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors. J Exp Med. 1977 Dec 1;146(6):1511–1520. doi: 10.1084/jem.146.6.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sezzi M. L., Bellelli L., Nista A. Peritoneal macrophages and neoplastic cells. I. Macrophages activity induced by heavily-irradiated or heat-killed cancer cells. Oncology. 1972;26(6):529–539. doi: 10.1159/000224707. [DOI] [PubMed] [Google Scholar]
  9. Smyth M. J., Ortaldo J. R., Bere W., Yagita H., Okumura K., Young H. A. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol. 1990 Aug 15;145(4):1159–1166. [PubMed] [Google Scholar]
  10. da Silva Reinaldo J., da Silva Márcia G., Vilela Lízia C., Fecchio Denise. Antitumor effect of Bothrops jararaca venom. Mediators Inflamm. 2002 Apr;11(2):99–104. doi: 10.1080/09629350220131953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. da Silva Reinaldo J., da Silva Márcia G., Vilela Lízia C., Fecchio Denise. Cytokine profile of Ehrlich ascites tumor treated with Bothrops jararaca venom. Mediators Inflamm. 2002 Aug;11(4):197–201. doi: 10.1080/0962935029000041. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES